Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?

Autor: Di Brizzi EV; Dermatology Unit, University of Campania 'L. Vanvitelli'., Caccavale S; Dermatology Unit, University of Campania 'L. Vanvitelli'., Di Caprio R; Dermatology Unit, University of Campania 'L. Vanvitelli'., Cusano F; Department of Dermatology, San Pio Hospital, Benevento, Italy., De Pasquale R; U.O. Dermatologia, Ospedale San Marco, Catania, Italy., Falcomatà V; Great Metropolitan Hospital Bianchi Melacrino Morelli, Reggio Calabria, Italy., Foti C; Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, Bari, Italy., Giofrè C; U.O.C. Dermatology Unit, 'Papardo' Hospital, Messina, Italy., Gubinelli E; Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy., Mazzocchetti G; UOSD Dermatologia ASL1 Pescara, 65124 Pescara, Italy., Nicolini M; Carlo Urbani Hospital, Jesi, Ancona, Italy., Palazzo G; Dermatology, Ospedale distrettuale 'A. Lo Dico', Matera, Italy., Pescitelli L; Unit of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy., Puca RV; Department of Dermatology and Dermosurgery, AOSG San Giuseppe Moscati, 83100 Avellino, Italy., Sarno O; Department of Dermatology and Dermosurgery, AOSG San Giuseppe Moscati, 83100 Avellino, Italy., Balato A; Dermatology Unit, University of Campania 'L. Vanvitelli'.

Publikováno v: Dermatology practical & conceptual [Dermatol Pract Concept] 2024 Oct 30; Vol. 14 (4). Date of Electronic Publication: 2024 Oct 30.